Ashley Gallagher is an assistant editor at Pharmacy Times®. She graduated from St. Bonaventure University in 2020 in journalism and mass communications. Previously, she worked as a pharmacy technician for a retail chain.
Geron’s Imetelstat Demonstrates Positive Results in IMerge Phase 3 Trial for Lower-Risk MDS
Study meets primary and key secondary endpoints, showing clinically meaningful and statistically significant improvements.
FDA Approves FoundationOne Liquid CDx to Identify Genomic Profile in NSCLC
The biopsy test is the first companion diagnostic approved for entrectinib for individuals who do not have an available tissue sample.
Generous Parental Leave Protects Against Poorer Mental Health, Study Results Show
Mothers, in particular, benefit when they are given longer leaves and policies that offer incentives or wage replacement, analysis indicates.
Study: Common Fatty Acid Contributes to Pain, Temperature Sensitivity in Psoriasis Plaques
Results show an association between linoleic acid, found in nuts, seeds, and vegetable oils, and increased hypersensitivity in psoriatic lesions.
FDA Approves Briumvi for Relapsing Multiple Sclerosis
Ublituximab-xiiy from TG Therapeutics Inc is the first anti-CD20 monoclonal antibody approved for individuals with RMS that is administered as a 1-hour infusion after the starting dose.
FDA Grants Breakthrough Therapy Designation to Adagrasib, Cetuximab Combination
The findings show promising clinical activity and a favorable tolerability profile in the treatment of KRASG12C-mutated advanced colorectal cancer.
FDA Accepts for Review BLA for Pfizer’s Pentavalent Meningococcal Vaccine Candidate
MenABCWY combines components of 2 vaccines, which help protect against serogroups that cause most cases of the invasive disease.
Study Results Show Direct Evidence of Serotonin Disruption Linked With Depression
First direct evidence of diminished 5-HT release proves hypothesis, according to a new analysis published in Biological Psychiatry.
Transparency Makes Cost-Plus Drug Pharmacies a Unique Business Model
Without company or insurance contracts, controlled medication prices reduce burden on patients.
NIH Awards $7.8 Million for Antibiotic Study of Patients With Emphysema, HIV
The National Institute of Health’s grant funds a phase 2 clinical trial of doxycycline in a large group of individuals with the 2 conditions who are smokers or used to smoke.
Study: Imbruvica for CLL Is Less Likely to Lead to Next-Line Treatment Than Acalabrutinib
Results show possible impact of using Janssen Pharmaceuticals’ ibrutinib in the front-line setting, providing additional data on chronic lymphocytic leukemia therapies.
Top 5 Most Read Zoster Articles in 2022
From newsworthy moments to groundbreaking research, these are the most popular articles in the zoster space, published on Pharmacy Times® during 2022.
FDA Approves Tocilizumab as First Monoclonal Antibody Treatment of COVID-19
Intravenous tocilizumab (Actemra; Genentech) has been approved for the treatment of COVID-19 in individuals who are hospitalized and receiving systemic corticosteroids and supplemental oxygen.
Study: Vitamin D3 Reduces Risk of Arsenic-Mediated Skin Cancer
Calcitriol may offer protection from the harmful effects of the chemical in drinking water, analysis shows.
RAB27A Increases Proliferation, Migration, Cell Invasion in Colorectal Cancer
The protein is vitally important and could be a prognostic indicator and potential therapeutic target.
Study: Intermittent Fasting Shows Link to Diabetes Remission
TD2 remission is defined as a hemoglobin A1C level of less than 6.5% at least 1 year after stopping medication, investigators say.
Top 5 Most Read Cholangiocarcinoma Articles in 2022
From newsworthy moments to groundbreaking research, these are the most popular articles in the cholangiocarcinoma space, published on Pharmacy Times® during 2022.
Guidelines for Cholangiocarcinoma Show Disconnect Between Goals, Implementation
Recommendations for the management of bile duct cancer benefit authorities, patients, and physicians, but investigators say more research is needed.
Top 5 Most Read IVIG Articles in 2022
From newsworthy moments to groundbreaking research, these are the most popular articles in the intravenous immunoglobulin space, published on Pharmacy Times® during 2022.
High Blood Pressure Medication Shows Potential in Preventing Damage from AKI
Investigators hope findings of study in mice help improve treatment for individuals with acute kidney injury.
Study Results Suggest Exercise, Mindfulness Do Not Boost Cognitive Function in Older Adults
Although physical activity and the practice of being present in the moment are associated with many benefits, analysis shows that neither led to measurable improvements in brain health.
Artificial Intelligence Shows Promise in Detection of Anxiety Disorders, Depression
Investigators establish that audio and/or facial video features have been most analyzed by machine learning, followed by electroencephalography signals.
Keytruda, mRNA Combination Cancer Vaccine Meets Primary Endpoint in Phase 2 Trial
Merck and Moderna’s adjuvant melanoma treatment shows reduced risk of recurrence or death by 44% compared with pembrolizumab alone.
FDA Accepts BLA for Denileukin Diftitox for Those With Cutaneous T-Cell Lymphoma
E7777 is an engineered interleukin-2-diphtheria toxin fusion protein that is a purified and more bioactive formulation of Ontak, which the agency previously approved.
Study: Weekly Vitamin D Does Not Affect Pediatric Development, Growth After 3 Years
A deficiency in the supplement is thought to be associated with early activation of the hypothalamic-pituitary gonadal axis, obesity, and stunting.
American Academy of Pediatrics Publishes Interim Guidance on Pediatric RSV
The updated recommendations during a surge in cases emphasize the need to enhance emergency readiness daily to not interrupt continuous care of children’s mental and physical well-being.
Study Results Show High Costs, Similar Benefits Lead Patients to Forgo Neurology Drugs
Despite the increasing approval of neurological medications, just a small percentage of individuals are using them because of skyrocketing out-of-pocket expenses.
Family Supporters Attending Programs Improve Patients’ Management of Diabetes
Relatives who attend low-intensity coaching and monitoring meetings increase individuals’ ability to manage the disease.
Telehealth Availability Is Linked to Better Mental Health Engagement in Those With Medicaid
Data show that despite declines in visit rates to federally qualified health centers, patients with psychological disorder diagnoses during COVID-19 did well when telemedicine was available.
FDA Grants Orphan Drug Designation to ZielBio’s ZB131 for Cholangiocarcinoma
The investigational drug is a monoclonal antibody with a high affinity and specificity for cancer-specific plectin, a cell surface protein that correlates with aggressive tumors and poor prognosis.
2 Clarke Drive Cranbury, NJ 08512